CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 57 filers reported holding CTI BIOPHARMA CORP in Q1 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $52,236,568 | -72.8% | 12,437,278 | -61.1% | 0.00% | -50.0% |
| Q4 2022 | $192,355,928 | +140.5% | 32,005,978 | +132.9% | 0.01% | +20.0% |
| Q3 2022 | $79,982,000 | +36.0% | 13,742,554 | +39.5% | 0.01% | +25.0% |
| Q2 2022 | $58,802,000 | +4541.0% | 9,849,528 | +3530.0% | 0.00% | – |
| Q1 2022 | $1,267,000 | +139.5% | 271,335 | +27.2% | 0.00% | – |
| Q4 2021 | $529,000 | -15.9% | 213,314 | 0.0% | 0.00% | – |
| Q3 2021 | $629,000 | +51.9% | 213,314 | +29.0% | 0.00% | – |
| Q2 2021 | $414,000 | +567.7% | 165,414 | +682.0% | 0.00% | – |
| Q1 2021 | $62,000 | +6.9% | 21,152 | +17.2% | 0.00% | – |
| Q4 2020 | $58,000 | +48.7% | 18,052 | 0.0% | 0.00% | – |
| Q3 2020 | $39,000 | +85.7% | 18,052 | 0.0% | 0.00% | – |
| Q2 2020 | $21,000 | +23.5% | 18,052 | 0.0% | 0.00% | – |
| Q1 2020 | $17,000 | -41.4% | 18,052 | 0.0% | 0.00% | – |
| Q4 2019 | $29,000 | +93.3% | 18,052 | 0.0% | 0.00% | – |
| Q3 2019 | $15,000 | -6.2% | 18,052 | 0.0% | 0.00% | – |
| Q2 2019 | $16,000 | -98.3% | 18,052 | -98.1% | 0.00% | – |
| Q1 2019 | $930,000 | +37.4% | 958,865 | +3.9% | 0.00% | – |
| Q4 2018 | $677,000 | -63.4% | 922,844 | +7.7% | 0.00% | – |
| Q3 2018 | $1,849,000 | -55.5% | 856,518 | +2.5% | 0.00% | – |
| Q2 2018 | $4,159,000 | +2980.7% | 835,478 | +2319.6% | 0.00% | – |
| Q1 2018 | $135,000 | +132.8% | 34,529 | +60.6% | 0.00% | – |
| Q4 2017 | $58,000 | +61.1% | 21,505 | +94.6% | 0.00% | – |
| Q3 2017 | $36,000 | -2.7% | 11,051 | 0.0% | 0.00% | – |
| Q2 2017 | $37,000 | -21.3% | 11,051 | 0.0% | 0.00% | – |
| Q1 2017 | $47,000 | +4.4% | 11,051 | -90.0% | 0.00% | – |
| Q4 2016 | $45,000 | – | 110,544 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|